Position in NKTX
as of Jun 30, 2026
· filed Jul 27, 2026
Position Value
$115,322
-$82,636 QoQ
Shares Held
40,750
-56.6% QoQ
Ownership
0.057%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#68
of 136 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NKTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Samalin Investment Counsel, LLC holds $218,633 across 2 Biotechnology names. NKTX ranks #1 (52.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | NKTX |
Nkarta, Inc.
This page
|
40,750 | $115,322 | |
| 2 | KYTX |
Kyverna Therapeutics, Inc.
|
11,595 | $103,311 |
All Filings in NKTX
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $115,322 | 40,750 | Shares | Sole | 2026-07-27 | |
| 2026-03-31 | $197,958 | 93,819 | Shares | Sole | 2026-04-23 | |
| 2025-12-31 | $277,934 | 150,235 | Shares | Sole | 2026-01-30 | |
| 2025-09-30 | $290,141 | 140,165 | Shares | Sole | 2025-10-30 | |
| 2025-06-30 | $259,665 | 156,425 | Shares | Sole | 2025-08-07 | |
| 2025-03-31 | $282,302 | 153,425 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $210,591 | 84,575 | Shares | Sole | 2025-02-11 | |
| No filing history on record for this holder in this stock. | ||||||